Navigation Links
OncoGenex Reports First Quarter Financial Results
Date:5/7/2009

A via the Special Protocol Assessment process, each in second-line treatment of advanced prostate cancer, featuring either survival or pain palliation as the primary endpoint. We believe these SPA agreements with the FDA together with our Phase 2 survival data position OGX-011 as an attractive asset. These regulatory achievements along with recent clinical data have supported our discussions with potential development and commercialization partners."

Conference Call Today at 4:30 p.m. ET

OncoGenex management will host a conference call at 4:30 p.m. Eastern Time today to provide a business update and discuss the first quarter results. A live webcast will be available through the Events and Presentations Web page found in the Investor Relations section of the OncoGenex Web site at www.ir.oncogenex.com. Alternatively, you may access the live conference call by dialing 800-967-7143 (U.S. & Canada) or 719-325-2413 (International). A webcast replay will be available approximately two hours after the call and will be archived at the same Web location for 90 days.

About OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase 1 clinical development; SN2310 has completed the Phase 1 clinical trial; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information about OncoGenex is available at

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
2. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
3. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
4. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
5. OncoGenex Pharmaceuticals to Webcast Financial Results for Fourth Quarter and Fiscal Year 2008 and Provide Outlook for 2009
6. OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
7. OncoGenex To Present At The RBC Capital Markets 2008 Healthcare Conference
8. OncoGenex Reports Third Quarter Financial Results
9. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 BioClinica®, Inc., a ... Solutions, today announced three of its experts are speaking ... Clinical Data Management to be held September 28 to ... . The Company also announced the innovative Compass ... quality in clinical trials acquired earlier this year, is ...
(Date:9/17/2014)... , Sept. 17, 2014 Alternative Fuels Americas, Inc. ... form a Special Purpose Vehicle in partnership with Jatro Greentech, ... agro energy company. The SPV shall be called AFAI Jatro ... AFAI as majority shareholder. The SPV shall pursue Jatropha planting ... particularly Ethiopia . "Although ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Beckman ... advances science and healthcare, has renewed its agreement with ... As part of the agreement, Personify will continue to ... sustained emphasis on recruitment analytics, including time-to-fill, time-to-source and ... renew our agreement with Personify was based on the ...
(Date:9/17/2014)... 2014 The Alliance for ... multi-stakeholder non-profit collaborative building a global system to ... today announced Phase 3 of its Site Accreditation ... Amir H. Kalali, Vice-President, Global Head, Neuroscience Center ... Compliance and Quality Integration (CQI) Consulting will lead ...
Breaking Biology Technology:BioClinica to Present at 20th Annual SCDM Conference 2BioClinica to Present at 20th Annual SCDM Conference 3AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4
... MADISON The push to amend the Wisconsin Constitution to ... in one of the states longest books the need ... a Taxpayer Bill of Rights is a best-seller or a ... Wisconsin changes how government raises and spends money. , ,Republican ...
... Information Networks Corp . President Paul Shain spoke ... of Accelerate Madisons monthly meeting. According to Shain, Berbees unique ... of the dot-com era as other information technology-focused companies failed. ... company was founded on the dogma of creating an environment ...
... who signs the paychecks in your organization. Most of us ... to whom. We might even know one or two board ... you much about who your IT staff is really working ... members become moles in your organization as they further the ...
Cached Biology Technology:Debate over Taxpayer Bill of Rights shows need for true tax reform 2Berbees success is based on companys history and culture 2Berbees success is based on companys history and culture 3Berbees success is based on companys history and culture 4Who does your IT staff work for? 2Who does your IT staff work for? 3
(Date:9/17/2014)... at IMIM (Hospital del Mar Medical Research Institute) and ... published a study in eLife showing that ... the evolution of new proteins, some of which could ... produce proteins from the instructions found in an RNA ... RNA containing information for the synthesis of proteins, meaning ...
(Date:9/17/2014)... retinoblastoma protein gene are a leading cause of eye ... fruit fly eyes to unlock the secrets of this ... on the cover of the current issue of the ... researchers provide the first detailed examination of a set ... cancer gene, said Irina Pushel, MSU undergraduate and co-author. ...
(Date:9/17/2014)... R.I. [Brown University] After decades of decline, grasses ... saltmarshes. To the eye, the marsh in those places ... that a key service of the marsh coastal ... back but the ecosystem function hasn,t come back," said ... senior author of the study in the journal ...
Breaking Biology News(10 mins):Parts of genome without a known function may play a key role in the birth of new proteins 2Abnormal properties of cancer protein revealed in fly eyes 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... Cincinnati Children,s Hospital Medical Center has developed an antibody ... afflict hospitalized patients who receive central lines. Margaret ... and her team developed the antibody, which prevents ... the formation of biofilm in a rat model of ...
... The Entomological Society of America is pleased to announce ... be presented at Entomology 2013, ESA,s 61st Annual Meeting ... PROFESSIONAL AWARDS RECOGNITION AWARD IN ENTOMOLOGY ... recognizes entomologists who are making significant contributions to agriculture. ...
... The search for the cause of multiple sclerosis, a debilitating ... the United States, has confounded researchers and medical professionals for ... New Jersey Medical School, has now found an important clue ... research on the origins of MS has focused on the ...
Cached Biology News:Entomological Society of America announces 2013 awardees 2Entomological Society of America announces 2013 awardees 3Entomological Society of America announces 2013 awardees 4Entomological Society of America announces 2013 awardees 5Entomological Society of America announces 2013 awardees 6Entomological Society of America announces 2013 awardees 7Entomological Society of America announces 2013 awardees 8Entomological Society of America announces 2013 awardees 9Entomological Society of America announces 2013 awardees 10Entomological Society of America announces 2013 awardees 11Entomological Society of America announces 2013 awardees 12Entomological Society of America announces 2013 awardees 13Entomological Society of America announces 2013 awardees 14Entomological Society of America announces 2013 awardees 15Multiple sclerosis appears to originate in different part of brain than long believed 2Multiple sclerosis appears to originate in different part of brain than long believed 3